ReviewCurrent psychiatry reports2015
Late-life psychosis: diagnosis and treatment.
Review in Current psychiatry reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 177 citations in OpenAlex.
- Initial physical health assessment for psychosis in Australia and New Zealand: 2026 recommendations.The Australian and New Zealand journal of psychiatry · 2026Guideline
- Epidemiology of Severe Mental Disorders in Older Adults: A Population-Based Longitudinal Study in Aragón, Spain.Healthcare (Basel, Switzerland) · 2026Article
- Study on the final diagnosis of nervous system diseases with psychiatric symptoms as manifestation onset.BMC psychiatry · 2025Article
- Diagnostic Transitions from Primary Psychiatric Disorders to Underlying Medical Conditions: A 5-Year Retrospective Survey from a University Hospital Sample.Alpha psychiatry · 2024Article
- Advances in the Diagnosis and Management of Psychotic Symptoms in Neurodegenerative Diseases: A Narrative Review.Journal of geriatric psychiatry and neurology · 2023Review
- Ectopic parathyroid adenoma causing hyperparathyroidism-induced psychosis: A case report.SAGE open medical case reports · 2023Article
- Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States.BMC geriatrics · 2022Article
- Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients.International journal of molecular sciences · 2022Article
- Clinical Approaches to Late-Onset Psychosis.Journal of personalized medicine · 2022Review
- Factors associated with late-life psychosis in primary care older adults without a diagnosis of dementia.Social psychiatry and psychiatric epidemiology · 2022Article
- Universal healthcare coverage for first episode of schizophrenia-spectrum disorders in Chile: analysis of the administrative database.European archives of psychiatry and clinical neuroscience · 2022Article
- Low continuation of antipsychotic therapy in Parkinson disease - intolerance, ineffectiveness, or inertia?BMC neurology · 2021Article
- A Non-Invasive Prediction Model for Non-Alcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Based on the Population of Northern Urumqi, China.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021Article
- Psychotropic medication use patterns in home-based primary care: A scoping review.The mental health clinician · 2020Article
- [Psychiatrists in palliative care of people with severe psychiatric illnesses and an oncological comorbidity].Der Nervenarzt · 2020Review
- Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer's and non-Alzheimer's dementia.Alzheimer's research & therapy · 2020Article
- Psychotic disorders in late life: a narrative review.Therapeutic advances in psychopharmacology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psychosis is one of the most common conditions in later life with a lifetime risk of 23 %. Despite its high prevalence, late-onset psychosis remains a diagnostic and treatment dilemma. There are no reliable pathognomonic signs to distinguish primary or secondary psychosis. Primary psychosis is a diagnosis of exclusion and the clinician must rule out secondary causes. Approximately 60 % of older patients with newly incident psychosis have a secondary psychosis. In this article, we review current, evidence-based diagnostic and treatment approaches for this heterogeneous condition, emphasizing a thorough evaluation for the "six d's" of late-life psychosis (delirium, disease, drugs dementia, depression, delusions). Treatment is geared towards the specific cause of psychosis and tailored based on comorbid conditions. Frequently, environmental and psychosocial interventions are first-line treatments with the judicious use of pharmacotherapy as needed. There is an enormous gap between the prevalence of psychotic disorders in older adults and the availability of evidence-based treatment. The dramatic growth in the elderly population over the first half of this century creates a compelling need to address this gap.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.